Unjha Formulations Ltd.

BSE: UNJHAFOR531762ISIN INE576D01015

Healthcare
Pharmaceuticals

Share price

₹27.88+1.32 (+4.97%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹36.38
52W low: ₹17.52
Off 52W high: -23.36%
1M return: -12.88%
3M return: +11.08%
6M return: +29.80%
1Y return: +21.22%
20D avg volume: 2,415
50 DMA: ₹30.23
200 DMA: ₹23.93

Key ratios Standalone

Market cap: ₹12.49 Cr
Current price: ₹27.88
52W high / low: ₹36.38 / ₹17.52
Face value: ₹10.00
P/E: 26.55
P/B: 3.76
EPS (TTM): ₹1.05
Book value / share: ₹7.41
ROE: 14.22%
ROCE: 18.60%
Operating margin: 5.89%
Net margin: 4.75%
Debt / equity: 0.00
Net debt: ₹-1.64 Cr
Interest cover: 96.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 46.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	3.31	3.28	4.41	4.29	3.61	2.37	3.76	3.78	3.95	—
	0.00	0.05	0.03	0.06	0.02	0.07	0.01	0.03	0.00	—
	3.31	3.33	4.44	4.35	3.63	2.44	3.77	3.81	3.95	—
	3.15	3.82	4.20	3.53	3.24	2.73	3.55	3.92	3.25	—
	3.20	3.14	3.38	2.79	2.69	2.11	2.98	3.40	2.84	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.21	0.34	0.32	0.15	0.13	0.36	0.20	0.12	0.18	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.04	0.04	0.04	0.03	0.03	0.03	0.02	0.02	0.02	—
	0.27	0.26	0.45	0.56	0.38	0.12	0.35	—	0.22	—
	0.16	-0.49	0.24	0.82	0.39	-0.29	0.22	-0.11	0.70	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.16	-0.49	0.24	0.82	0.39	-0.29	0.22	-0.11	0.70	—
	0.00	0.25	0.00	0.00	0.00	0.12	—	—	—	—
	0.16	-0.74	0.24	0.82	0.39	-0.41	0.22	-0.11	0.70	—
	0.35	-1.66	0.53	1.83	0.90	-0.91	0.50	-0.25	1.56	—
Key metrics
	0.20	-0.45	0.28	0.85	0.42	-0.26	0.24	-0.09	0.72	—
	6.00%	-13.70%	6.30%	19.80%	11.60%	-11.00%	6.40%	-2.40%	18.20%	—
	4.80%	-22.60%	5.40%	19.10%	10.80%	-17.30%	5.90%	-2.90%	17.70%	—
	—	-9.50%	—	18.90%	—	-9.20%	—	—	—	—
	-8.30%	38.40%	17.30%	13.50%	-8.60%	—	—	—	—	—
	-59.00%	-80.50%	9.10%	845.50%	-44.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	15.29	15.59	13.86	—
	0.14	0.16	0.12	—
	15.43	15.75	13.98	—
	14.70	14.79	13.45	—
	12.51	12.00	11.32	—
	0.00	0.00	0.00	—
	1.02	0.94	0.81	—
	0.00	0.01	0.01	—
	0.15	0.14	0.10	—
	1.54	1.66	1.11	—
	0.73	0.95	0.52	—
	0.00	0.00	0.00	—
	0.73	0.95	0.52	—
	0.25	0.25	0.12	—
	0.48	0.70	0.41	—
	1.05	1.57	0.91	—
Key metrics
	0.88	1.10	0.63	—
	5.76%	7.10%	4.50%	—
	3.14%	4.50%	3.00%	—
	—	18.60%	16.80%	—
	13.09%	12.50%	—	—
	433.33%	70.70%	—	—
	—	1.24	-0.04	—
	—	1.77	-0.10	—
	—	0.00	0.00	—
	—	-1.64	-0.64	—
	—	46.3	36.1	—
Balance sheet
	—	5.51	4.56	—
	—	4.21	3.35	—
	—	1.64	0.64	—
	—	1.35	1.51	—
	—	0.63	1.03	—
	—	0.59	0.06	—
	—	0.80	0.70	—
	—	0.00	1.17	—
	—	0.36	1.41	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	3.84	3.14	—
Cash flow
	—	1.24	-0.04	—
	—	-0.23	-0.18	—
	—	-0.01	-0.01	—
	—	0.00	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +13.09%
Profit YoY (TTM): +433.33%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 36.92%

Quarter	September 2026	June 2026
Promoter %	36.92%	36.92%

Holder	Type	Holding	Previous	Change
JASHODABEN SHAMBHUBHAI PATEL	Promoter	16.51%	16.51%	0.00%
KRUTIBEN MAYANKKUMAR PATEL	Promoter	14.89%	14.89%	0.00%
URVESHKUMAR SHAMBHUBHAI PATEL	Promoter	3.62%	3.62%	0.00%
NEENABEN URVESHKUMAR PATEL	Promoter	1.90%	1.90%	0.00%
Esha Mayank Patel	Public	1.60%	1.60%	0.00%
Deep Mayankbhai Patel	Public	1.29%	1.29%	0.00%
Manishkumar Joitaram Patel	Public	1.28%	1.28%	0.00%
Narveer Yadav	Public	1.17%	1.17%	0.00%
Jatinkumar Babulal Patel	Public	1.06%	1.06%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Unjha Formulations Ltd. S	12	27.88	26.55	18.60%	+13.09% TTM	+433.33% TTM	+21.22%

Filings & corporate actions

Recent announcements

Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve REGULATION 29(1)(a) of SEBI(LODR) ....22 Oct 2026 · Board Meeting / Board Meeting
Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve REGULATION 29(1)(a) of SEBI(LODR) 201522 Oct 2026 · Board Meeting / Board Meeting
Regulation 40(9) of SEBI(LODR) 201522 Oct 2026 · Company Update / Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of XML file for Financial Statement as on 31/03/20268 Sep 2026 · Company Update / General
Submission of XML file for Financial Statement as on 31/03/20268 Sep 2026 · Company Update / General
Regulation 44(3) of SEBI(LODR) Regulation,201514 Aug 2026 · AGM/EGM / AGM
REGULATION 44(3) OF SEBI(LODR) REGULATION ,2015 / SCRUTINIZER REPORT14 Aug 2026 · AGM/EGM / AGM
As per Regulation of SEBI(LODR) Regulation,201514 Aug 2026 · Company Update / General
Cash Flow Statement for the year ended 31.03.202614 Aug 2026 · Company Update / General
Cash Flow Statement for the year ended 31.03.202614 Aug 2026 · Company Update / General
REGULATION 30 OF THE SEBI (LODR) 2015, OUTCOME OF AGM HELD ON 14-08-202614 Aug 2026 · AGM/EGM / AGM
REG 33 (3) OF SEBI (LODR) ACT 20155 Aug 2026 · Company Update / General
Regulation 33 of SEBI(LODR) Act 20153 Aug 2026 · Result / Financial Results
Regulation 33 of the SEBO(LODR) Act 20153 Aug 2026 · Board Meeting / Outcome of Board Meeting
Section 108 of companies act , 201328 Jul 2026 · Company Update / General
Regularion 30 & 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 201520 Jul 2026 · Company Update / General
Regulation 34(1) of SEBI(LODR) Act 201520 Jul 2026 · Others / Reg. 34 (1) Annual Report
Published Notice of AGM in LokMitra (Gujarati) and Free Press (English) non 18/07/202620 Jul 2026 · Company Update / General
NOTICE OF 32TH ANNUAL GENERAL MEETING OF COMPANY16 Jul 2026 · Company Update / General
Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve REGULATION 29(1) A OF SEBI LODR16 Jul 2026 · Board Meeting / Board Meeting
Reply to clqarification on price movement15 Jul 2026 · Company Update / General
News papers Advertisement for 32th Annual General Meeting15 Jul 2026 · Company Update / General
Compliance Certificate under Regu 74(5) of SEBI (DP Regulations15 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has sought clarification from Unjha Formulations Ltd on July 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....13 Jul 2026 · Company Update / Clarification
REGULATION 42(2) OF SEBI LODR, REGULATIONS 201513 Jul 2026 · Corp. Action / Book Closure
Regulation 42 of SEBI (LODR) Act 20153 Jul 2026 · Corp. Action / Book Closure
Annual General Meeting to be held on 14th August,20263 Jul 2026 · Company Update / General
Annual Large corporate Disclosure 20252623 Jun 2026 · Company Update / General
REGULATION 6(1) AND 30(4) WITH PART A OF SCH II OF SEBI(LODR)REGULATION,20151 Jun 2026 · Company Update / General
Regulation 33(3) of SEBI (lodr) 201520 May 2026 · Company Update / General
Regulation 33(3) of SEBI (lodr) 201520 May 2026 · Company Update / General
INTEGRATED FILING18 May 2026 · Company Update / General
REGULATION 33 OF SEBI LODR 201518 May 2026 · Board Meeting / Outcome of Board Meeting
Declaration with respect to non-applicability of large corporate vide SEBI circular Dated 26.11.20187 May 2026 · Company Update / General
Declaration with respect to non-applicability of large corporate vide SEBI circular Dated 26.11.20187 May 2026 · Company Update / General
Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve Regulation 29(1)(a) of SEBI(LODR),201522 Apr 2026 · Board Meeting / Board Meeting
Regulation 74(5) of SEBI (DP) Regulation10 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Regu 31(4) of SEBI ( Sub Acq of share and takeovers) Regulation 20112 Apr 2026 · Company Update / General
Regulation 30(1) and 30(2) of SEBI ( Sub Acq of share & takeovers) Regu 20112 Apr 2026 · Company Update / General

Board meetings

5 Nov 2026 Board Meeting - Financial Results
3 Aug 2026 Board Meeting - Financial Results